Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

Foresee Pharma announces preliminary results from phase 1 trial, highlighting promising safety, tolerability and PK profile of linvemastat: Taipei, Taiwan Tuesday, October 22, 202 ...

Most of us have experienced anxiety or will at some point in the future. It's normal to feel worried from time to time.

The global Chronic Obstructive Pulmonary Disease (COPD) treatment market is projected to experience steady growth over the ...

With high proficiency, a deep-learning model identified contents of vials and syringes, confirming whether medication ...

While cannabis has historically been more popular with younger groups, a growing number of older adults are turning to the drug for a variety of reasons — but are the potential benefits worth the risk ...

Thanks to mass immunization campaigns, by the year 2000, measles, once a common childhood illness with severe complications, ...

The RespiriNTM project has received funding from the Innovative Health Initiative 2 Joint Undertaking (JU) under grant agreement No 853932. This Joined Undertaking receives support from the European ...

Qnovia, Inc. announced its CEO is speaking publicly to FDA and NIH at the joint agency public meeting on Advancing Smoking Cessation today at FDA's White Oak Campus. Qnovia is a pharmaceutical company ...

Asthma affects approximately 262 million people globally, with the number of asthma incidents having increased by around 15% ...

Just how often is it considered normal to catch a cold? Here, doctors break it down, share what do do when you get sick and ...

Algoma Public Health’s Community Health Profile, made public in September, outlines important health-related data for Algoma ...